Utilization of human papillomavirus testing for cervical cancer prevention in a university hospital

Cadernos de Saude Publica

Volumn 23, Issue 6, 2007, Pages 1309-1318

  Nomelini, Rosekeila Simões ^a   Macêdo Barcelos, Ana Cristina ^a   Michelin, Márcia Antoniazi ^a   Adad, Sheila Jorge ^a   Murta, Eddie Fernando Candido ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Cervical intraepithelial neoplasia; Colposcopy; Health care costs; Polymerase chain reaction

Indexed keywords

EID: 34249984147     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2007000600006     Document Type: Article

References (43)

1. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988; 10:122-63.
2. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995; 76:1888-901.
3. Murta EFC, Souza MAH, Falco VA, Lombardi W, Borges LS. Importância da infecção pelo papilomavírus humano na incidência da neoplasia intraepitelial cervical. J Bras Ginecol 1997; 107:361-6.
4. Murta EFC, França HG, Carneiro MC, Caetano MSSG, Adad SJ, Sousa MAH. Câncer do colo uterino: correlação com início da atividade sexual e paridade. Rev Bras Ginecol Obstet 1999; 21:555-9.
5. Murta EFC, Souza MAH, Adad SJ, Pires RA, Matthes AGZ. Influência da idade materna, do período gestacional e do número de gestações na infecção pelo papilomavírus humano. Rev Bras Ginecol Obstet 1998, 20:33-5.
6. Sardana S, Sodhani P, Agarwal SS, Sehgal A, Roy M, Singh V, et al. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears. Acta Cytol 1994; 38:693-7.
7. Derchain SF, Roteli-Martins CM, Syrjanen KJ, Abreu HJ, Martinez EZ, Alves VA. Association of oncogenic human papillomavirus HPV-DNA with high-grade cervical intraepithelial neoplasia (CIN 2 or 3): the role of cigarette smoking. Sex Transm Infect 1999; 75:406-8.
8. Denny LA, Wright TC. Human papillomavirus testing and screening. Best Pract Res Clin Obstet Gynaecol 2005; 20:501-15.
9. Adad SJ, Sousa MAH, Etchebehere RM, Saldanha JC, Falco VAA, Murta EFC. Cyto-histological correlation of 219 patients submitted to surgical treatment due to diagnosis of cervical intra-epithelial neoplasia. São Paulo Med J 2000; 117:81-4.
10. Morin C. Comparison of the hybrid capture test and polymerase chain reaction in identifying women with an ASCUS Pap smear who need colposcopy. J Lower Genital Tract Dis 1999; 3:231-8.
11. Eltabbakh GH, Lipman JN, Mount SL, Morgan A. Significance of atypical squamous cells of undetermined significance on ThinPrep Papanicolaou smears. Gynecol Oncol 2000; 79:44-9.
12. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93:293-9.
13. The ALTS Group. Human papillomavirus testing for the triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000; 92:397-402.
14. Wright Jr. TC, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-9.
15. Wright Jr. TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ; ASCCP-Sponsored Consensus Conference. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287:2120-9.
16. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Nagai J, Kurman RJ, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999; 281:1605-10.
17. Stafl A, Wilbanks GD. An international terminology of colposcopy: report of the nomenclature committee of the International Federation of Cervical Pathology and Colposcopy. Obst Gynecol 1991; 77:313-4.
18. Roteli-Martins CM, Alves VA, Santos RT, Martinez EZ, Syrjanen KJ, Derchain SF. Value of morphological criteria in diagnosing cervical HPV lesions confirmed by in situ hybridization and hybrid capture assay. Pathol Res Pract 2001; 197:677-82.
19. Yamamoto LS, Alves VA, Maeda MY, Longatto-Filho A, Utagawa ML, Eluf Neto J. A morphological protocol and guide-list on uterine cervix cytology associated to Papillomavirus infection. Rev Inst Med Trop Sao Paulo 2004; 46:189-93.
20. Sarkar FH, Crissman JD. Detection of human papilloma virus DNA sequences by polymerase chain reaction. Biotechniques 1990; 9:180-5.
21. Tamim H, Finan RR, Sharida HE, Rashid M, Almawi WY. Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis 2002; 43:277-81.
22. Da Silva CS, Adad SJ, Hazarabedian-de-Souza MA, Macedo-Barcelos AC, Sarreta-Terra AP, Murta EF. Increased frequency of bacterial vaginosis and Chlamydia trachomatis in pregnant women with human papillomavirus infection. Gynecol Obstet Invest 2004; 58:189-93.
23. Arango HG. Bioestatística teórica e computacional. Rio de Janeiro: Editora Guanabara Koogan; 2001.
24. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CA, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169:235-40.
25. Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection is a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87:1365-71.
26. Elgren K, Kalantari M, Moberger B, Hagmar B, Dillner J. A population based 5-year follow-up study of cervical human papillomavirus infection. Am J Obstet Gynecol 2000; 183:561-7.
27. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, et al. Baseline cytology, human papillomavirus testing and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003; 95:46-52.
28. Olaniyan OB. Validity of colposcopy in the diagnosis of early cervical neoplasia - a review. Afr J Reprod Health 2002; 6:59-69.
29. Cuzick EB, Ho L, Sapper H, Mielzynska I, Lorincz A, Chan WK, et al. HPV testing in primary screening of older women. Br J Cancer 1999; 81:554-8.
30. Venturolli S, Bonvicini F, Giosa F, Pulvirente FR, Galli C, Musiani M, et al. Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results. J Clin Virol 2002; 25:177-85.
31. Bozzetti M, Nonnenmacher B, Mielzinska II, Villa L, Breitenbach VV, Prolla J. Comparison between hybrid capture II and polymerase chain reaction results among women at low risk for cervical cancer. Ann Epidemiol 2000; 10:466.
32. Nonogaki S, Wakamatsu A, Longatto Filho A, Pereira SM, Utagawa ML, Ferreira-Alves VA, et al. Hybrid capture II and polymerase chain reaction for identifying HPV infections in samples collected in a new collection medium: a comparison. Acta Cytol 2004; 48:514-20.
33. Cope JU, Hildesheim A, Schiffman MH, Manos MM, Lorincz AT, Burk RD, et al. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol 1997; 35:2262-5.
34. Nindl I, Zanm DM, Meijer CJ, Walboomers JM, Schneider A. Human papillomavirus detection in high-grade squamous intraepithelial lesions. Comparison of hybrid capture assay with a polymerase chain reaction system. Diagn Microbiol Infect Dis 1995; 23:161-4.
35. Kulmala SM, Syrjanen S, Shabalova I, Petrovichev N, Kozachenko V, Podistov J, et al. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol 2004; 42:2470-5.
36. Lonky NM, Felix JC, Naidu YM, Wolde-Tsadik G. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation. Obstet Gynecol 2003; 101:481-9.
37. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001; 89:1616-23.
38. Franco EL. Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst 2003; 92:818-25.
39. Zerbini M, Venturoli S, Cricca M, Gallinella G, De Simone P, Costa S, et al. Distribution and viral load of type-specific HPVs in different cervical lesions as detected by PCR-ELISA. J Clin Pathol 2001; 54:377-80.
40. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003; 362:1871-6.
41. Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E, et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 1995; 171:1026-30.
42. Schneider A, Koutsky L. Natural history and epidemiological features of genital HPV infection. In: Munoz, N, Bosh FX, Shah KV, Meheus A, editors. The epidemiology of cervical cancer and human papillomavirus. Lyon: International Agency for Research on Cancer; 1992. p. 25-52.
43. Schneider A, Kirchhoff T, Meinhardt G, Gissmann L. Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears. Obstet Ginecol 1992; 79:683-8.